PROSPECTS AND OPPORTUNITIES
Pioneering sustainability and innovation in adult incontinence care
Rx/reimbursement adult incontinence in Brazil is expected to maintain slow and stable volume growth, while value growth at constant 2024 prices is set to be negligible. The future of Rx/reimbursement adult incontinence in the country is set to be shaped by significant investments in sustainability and technological innovation.
Expanding access and promoting social inclusion
The expansion of the Farmácia Popular programme will continue to play a pivotal role in improving access to RX/reimbursement adult incontinence products in Brazil. By offering these essential items at reduced or no cost, the programme ensures that vulnerable populations, including older people and those with disabilities, have access to necessary healthcare products.
Economic challenges will continue to force new strategies in the forecast period
Rx/reimbursement adult incontinence in Brazil faces significant economic challenges, including the impact of global trade tensions and fluctuating raw materials costs. The ongoing trade war between China and the US has led to increased tariffs and disrupted supply chains, affecting the availability and cost of essential components.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Rx/Reimbursement adult incontinence industry in Brazil with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Rx/Reimbursement adult incontinence industry in Brazil, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Rx/Reimbursement adult incontinence in Brazil report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Rx/Reimbursement adult incontinence in Brazil?
- Which are the leading brands in Rx/Reimbursement adult incontinence in Brazil?
- How are products distributed in Rx/Reimbursement adult incontinence in Brazil?
- How is the rise of e-commerce changing the retail and competitive landscape?
- How has COVID-19 impacted demand? Where have sales increased due to stockpiling amidst national lockdown?
- How have enforced home seclusion and social distancing measures following COVID-19 changed usage patterns for Rx/Reimbursement adult incontinence products?
- Where is future growth expected to be most dynamic?
- How important will sustainability and recycling be in generating future growth?
Rx/Reimbursement Adult Incontinence in Brazil - Category analysis
KEY DATA FINDINGS
Overcoming challenges in Rx/reimbursement adult incontinence
The transformative impact of Brazil’s Farmácia Popular programme
Adapting the healthcare supply chain to geopolitical challenges
Pioneering sustainability and innovation in adult incontinence care
Expanding access and promoting social inclusion
Economic challenges will continue to force new strategies in the forecast period
Tissue and Hygiene in Brazil - Industry Overview
Tissue and hygiene in 2024: The big picture
2024 key trends
Competitive landscape
Retail developments
What next for tissue and hygiene?
DISCLAIMER
Rx/Reimbursement adult incontinence
To qualify for reimbursement, typically a note from a physician is required (a “prescription”) indicating that the patient is in need of incontinence supplies. Depending on the local system in place, supplies are then either shipped directly to consumer home by a designated service or a consumer has to pick up products at a pharmacy. Please be advised that services and routes to consumers can vary even within the same country and vary by state/region. Some countries provide reimbursement through income tax deductions. If this is the case in your market, we EXCLUDE this type of reimbursement from our Rx/Reimbursement coverage as it would be impossible to track. Additionally, consumers would have already purchased the products in retail before claiming tax deductions, and as such the products have already been counted as retail sales. The same logic applies to institutional sales. If a nursing home purchased adult incontinence products from a distributor/manufacturer for distribution to its patients/residents, these products would be included as AFH adult incontinence in our coverage, even though sometimes patients might claim healthcare deductions for costs of stay at a nursing home.
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Rx/Reimbursement adult incontinence research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!